Member Info for MrRipley

Unless of course it’s not going to make any money In which case it’s a complete waste of funding and energy.

Can you tell us how much the collaboration would be worth to us and how widely used the tech deepverge have is likely to be prof?

Avacta not wanting to spend any more time and money assisting a dead end revenue stream….

Haha basher day is it? Oh no. We now won’t get any revenue from a device that nobody will fit en masse anyway when it’s a struggle to sell LFTs in the first place. What will we do without that close to zero revenue stream?

Thing is Gracie, NDN was using therapeutic positivity as his anchor to prove he was actually a share holder here. He’d bash the LFT and then say something positive, just like the sealion does, and then we’d all have to collude in the allusion that he was invested. Now we’ve had positive therapeutic news the mask has slipped.
Ps…. I’ve heard he’s got a poster of Myles on his bedroom wall.

Too far lads….. too far

….Biggest fan.

Firstly the covid case number is beginning to drop. That’s great news. There’s a very long way to go and it’s lovely being from a 1st world country because a lot of the developing world are simply being abandoned. But it’s a start. One thing I’ve noted though is cases are down 38% from highs but they’re still nearly 100k a day and my issue with this is the 22% drop in tests being done per day. Boris is backing the testing off to make the drop in cases seem more dramatic I believe. It’s political ballet at its worst. But more cun(t)Ning than that is that he’s claiming he didn’t know what the rules were when he broke them. So I say to all, go to your local bank with a banana painted black and a Maggie Thatcher mask and rob yourself a few grand and whack it all on Avacta. If you’re arrested you can say you’re hypoglycaemic and that’s what the banana was for. If you’re sent to trial after they pull you on your flagrant lie you can simply say “nobody told me robbing a bank with a painted banana was illegal” and cite Boris the Peppa **** Johnson as your case referral.

- Note to all. The above is satirical. Robbing a bank with a banana would lead to a lengthy prison sentence and a different kind of illegal banana-ing in the showers.

I’ll sell one share when PreCision pays off and buy you this one?

Comes with a rumba beat button and organ mode. A lot here are masters at playing with an organ I reckon…..

https://www.argos.co.uk/product/9370487?istCompanyId=a74d8886-5df9-4baa-b776-166b3bf9111c&istFeedId=30f62ea9-9626-4cac-97c8-9ff3921f8558&istItemId=iatwatqxi&istBid=t&&cmpid=GS001&_$ja=tsid:59157%7Cacid:629-618-1342%7Ccid:9563523552%7Cagid:102230988150%7Ctid:pla-1162122878079%7Ccrid:423314716928%7Cnw:g%7Crnd:9359170650145981708%7Cdvc:m%7Cadp:%7Cmt:%7Cloc:9046549&utm_source=Google&utm_medium=cpc&utm_campaign=9563523552&utm_term=9370487&utm_content=shopping&utm_custom1=102230988150&utm_custom2=629-618-1342&gclid=CjwKCAiA55mPBhBOEiwANmzoQvQvj4lvg9qkW36EDhhjIWKnB939N3ZWaJ9BXKisR0c_h0zKJwtpJBoCw0AQAvD_BwE&gclsrc=aw.ds

It’s velcade.

I found this bit very very interesting;

“Proteasome inhibitors have a market that is expected to grow to $2.3bn by 2026[1], despite limited regulatory approvals of other molecules in this class due to their serious toxicities.”

This to me is a possible nod to AVA6000 seriously reducing toxicity via PreCision in the Pro-Doxorubicin trial. As is often stated the fact of the matter is the car was a great idea; the model T made cars more user friendly and accessible and massively increased the market size and so the Model T became massively successful. I believe PreCision will have the same effect on the Chemotherapy market, increasing the useability and market size of each therapeutic. And that’s before you add an affimer into the game with T-Mac. We few, we (mostly) happy few, we band of weirdos, could really be in early doors here on something great.

For balance it could all be total crap and we’ll all be sucking richards for a fiver a go in back alley ways to pay the rent. But I don’t think so.

Excellent summary. Thanks all. Even AgentB. Looks like I can take a day off then.
Great to see the market finally seeing some sense. I’m sure it’ll be a rocky road from being viewed as a covid stock to people seeing sense that we’re much much much more than that.
Sorry…. Did you say AS is improving investor relation? Christ. Just fell off my chair and I wasn’t even on one.

Anyone fancy giving me a b b b b breakdown of anything I’ve missed today? Ive been busier than a cat trying to bury a turd in a tiled floor.

I asked him to do some calculations on what Avacta will be worth in a couple of years time…. Had to hang up in the end…..

https://m.youtube.com/watch?v=Qry-IzXmlVQ

… now. This is just for starters. Alastair Smith re iterated that they’ve consistently stated they’re targeting “the end of Q4 or the start of Q1” for initial data. This for me is a great opening course.

Yes live and learn, they’ve spend a lot of time and money on this but below just to keep the PIs happy. They thought eh lads and ladies, shall we collate all manner of pre clinical data and release an RNS because some covid investors aren’t happy? I know this is the bread and butter of the company and it’s what the majority of the placing was intended for but you know…..

“Following a review of efficacy studies in several liquid and solid tumour models……..”

You’ve got to be an intentional twat to think this has anything to do with improving sentiment. It’s the core of Avacta business. It’s also a very strong indicator AVA6000 is going extremely well.

……, safety studies and a review of manufacturability, AVA3996 has been selected as a candidate for pre-clinical development with the aim of a Clinical Trial Authorisation (CTA) and/or Investigational New Drug (IND) filing in the first half of 2023 and dosing of the first patient later in the year.”

It’s not just a paper exercise.

In the grand scheme of things they’ve got some data on this and it looks very positive or they wouldn’t push on with it hence.

“Following a review of efficacy studies in several liquid and solid tumour models, safety studies and a review of manufacturability, AVA3996 has been selected as a candidate for pre-clinical development with the aim of a Clinical Trial Authorisation (CTA) and/or Investigational New Drug (IND) filing in the first half of 2023 and dosing of the first patient later in the year.”

So as trials of AVA6000 come to and end this will be rolling into clinic. It shows a MASSIVE HINT that the platform is working through AVA6000 or they wouldn’t be pushing funding into this.

Just admit you’re the Croydon cat killer and we can get you the help we need. Maybe start you off with some stuffed bears to put in a blender and work down from there until you can feel happy…. You know, In yourself.

https://m.youtube.com/watch?v=0p8oeiVDcx4

Wahayyy it’s AlwaysWnking! Long time pal

Eh, Ava6000 has barely progressed has it? Going from pre clinical to clinical? Being on the verge of initial data? An incredibly long road? Are you on life support champ? How is less than 18 months til the end of trials incredibly long? With steps in the SP as data is released? The rest of the company….. well….

25m plus still in the bank. Pre covid? A few million.
Proof of concept with Affimers via the LFT, BAMS and Elisa? Pre covid…. None of the above.
Expanded deal with LG worth 400m with a “significant milestone met”
Expanded deal with Daewoong with $7.3m raised in series A funding?
Deal with POINT with milestone payments, 8m per therapeutic.
Massively increased market exposure to our 3 IPs? But yeah….. nothings changed.

Hey everyone, how thick is this fella?

He’s so dreamy. And he’s a millionaire you know NDN. Seems like a man living a dream life to Me eggy, errr cooolaide errrrrr WynBishopG-man. Anyway. Really great thread on why we’re so undervalued. Have a read NDN. It’ll cheer you up eggy.

https://mobile.twitter.com/MylesMcNulty/status/1483101405980381190